$NHC
NATIONAL HEALTHCARE CORP

2016 Q1 Form 10-Q Financial Statement

#000104733516000214 Filed on May 03, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $229.6M $222.4M
YoY Change 3.23% 5.64%
Cost Of Revenue $130.0M $125.7M
YoY Change 3.42% 5.01%
Gross Profit $99.60M $96.70M
YoY Change 3.0% 6.5%
Gross Profit Margin 43.38% 43.48%
Selling, General & Admin $10.30M $10.00M
YoY Change 3.0% 1.01%
% of Gross Profit 10.34% 10.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.354M $8.933M
YoY Change 4.71% 13.08%
% of Gross Profit 9.39% 9.24%
Operating Expenses $81.00M $78.70M
YoY Change 2.92% 7.07%
Operating Profit $17.62M $17.44M
YoY Change 1.08% 2.64%
Interest Expense $954.0K $590.0K
YoY Change 61.69% -86.28%
% of Operating Profit 5.41% 3.38%
Other Income/Expense, Net $4.773M $4.222M
YoY Change 13.05% -7.66%
Pretax Income $22.40M $21.66M
YoY Change 3.41% 0.27%
Income Tax $8.698M $8.416M
% Of Pretax Income 38.84% 38.86%
Net Earnings $13.70M $13.24M
YoY Change 3.45% 0.1%
Net Earnings / Revenue 5.97% 5.95%
Basic Earnings Per Share $0.92 $0.80
Diluted Earnings Per Share $0.91 $0.77
COMMON SHARES
Basic Shares Outstanding 14.92M 13.76M
Diluted Shares Outstanding 15.14M 14.29M

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $175.1M $213.0M
YoY Change -17.79% 7.79%
Cash & Equivalents $49.18M $78.21M
Short-Term Investments $125.9M $134.8M
Other Short-Term Assets $30.50M $30.00M
YoY Change 1.67% -81.27%
Inventory $7.298M $7.100M
Prepaid Expenses
Receivables $81.73M $81.60M
Other Receivables $1.700M $400.0K
Total Short-Term Assets $296.3M $332.1M
YoY Change -10.79% -26.58%
LONG-TERM ASSETS
Property, Plant & Equipment $540.1M $518.4M
YoY Change 4.19% 4.26%
Goodwill $17.60M
YoY Change
Intangibles
YoY Change
Long-Term Investments $37.20M $35.60M
YoY Change 4.49% -1.39%
Other Assets $231.7M $175.7M
YoY Change 31.85% 860.11%
Total Long-Term Assets $771.8M $759.8M
YoY Change 1.58% 29.88%
TOTAL ASSETS
Total Short-Term Assets $296.3M $332.1M
Total Long-Term Assets $771.8M $759.8M
Total Assets $1.068B $1.092B
YoY Change -2.18% 5.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.90M $20.70M
YoY Change -13.53% 15.0%
Accrued Expenses $78.10M $72.50M
YoY Change 7.72% -52.61%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.300M $3.100M
YoY Change 6.45% 3.33%
Total Short-Term Liabilities $138.8M $180.4M
YoY Change -23.06% -27.32%
LONG-TERM LIABILITIES
Long-Term Debt $120.0M $42.70M
YoY Change 181.03% -6.77%
Other Long-Term Liabilities $16.79M $120.3M
YoY Change -86.04% 236.97%
Total Long-Term Liabilities $136.8M $163.0M
YoY Change -16.08% 100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $138.8M $180.4M
Total Long-Term Liabilities $136.8M $163.0M
Total Liabilities $275.6M $343.5M
YoY Change -19.77% 4.15%
SHAREHOLDERS EQUITY
Retained Earnings $375.6M
YoY Change
Common Stock $153.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $654.6M $748.4M
YoY Change
Total Liabilities & Shareholders Equity $1.068B $1.092B
YoY Change -2.18% 5.26%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income $13.70M $13.24M
YoY Change 3.45% 0.1%
Depreciation, Depletion And Amortization $9.354M $8.933M
YoY Change 4.71% 13.08%
Cash From Operating Activities $17.73M $24.38M
YoY Change -27.28% 61.46%
INVESTING ACTIVITIES
Capital Expenditures $13.43M $12.58M
YoY Change 6.77% -235.27%
Acquisitions
YoY Change
Other Investing Activities $1.800M -$1.300M
YoY Change -238.46% -55.17%
Cash From Investing Activities -$8.439M -$13.86M
YoY Change -39.1% 13.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $9.330M $5.036M
YoY Change 85.27%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.683M -2.079M
YoY Change -180.95% 246.5%
NET CHANGE
Cash From Operating Activities 17.73M 24.38M
Cash From Investing Activities -8.439M -13.86M
Cash From Financing Activities 1.683M -2.079M
Net Change In Cash 10.98M 8.444M
YoY Change 29.97% 267.13%
FREE CASH FLOW
Cash From Operating Activities $17.73M $24.38M
Capital Expenditures $13.43M $12.58M
Free Cash Flow $4.299M $11.80M
YoY Change -63.57% -51.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 nhc Stock Repurchase Program Number Of Plans
StockRepurchaseProgramNumberOfPlans
2
nhc Annual Excess Coverage
AnnualExcessCoverage
7500000
nhc Annual Excess Coverage
AnnualExcessCoverage
9000000
nhc Annual Excess Coverage
AnnualExcessCoverage
4000000
nhc Annual Excess Coverage
AnnualExcessCoverage
9000000
CY2016Q1 nhc Direct Business Coverage Statutory Limits
DirectBusinessCoverageStatutoryLimits
1000000
CY2016Q1 nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
1861000
CY2015Q1 nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
1876000
CY2016Q1 nhc Increase Decrease In Due To Third Party Payors
IncreaseDecreaseInDueToThirdPartyPayors
944000
CY2015Q1 nhc Increase Decrease In Due To Third Party Payors
IncreaseDecreaseInDueToThirdPartyPayors
1502000
CY2016Q1 nhc Number Of Assisted Living Facilities
NumberOfAssistedLivingFacilities
20
CY2016Q1 nhc Number Of Beds
NumberOfBeds
9256
CY2016Q1 nhc Number Of Homecare Programs
NumberOfHomecarePrograms
36
CY2016Q1 nhc Number Of Independent Living Facilities
NumberOfIndependentLivingFacilities
5
CY2016Q1 nhc Number Of Nursing Facilities Under Medicaid Cost Report Audits
NumberOfNursingFacilitiesUnderMedicaidCostReportAudits
11
CY2016Q1 nhc Number Of Skilled Nursing Centers
NumberOfSkilledNursingCenters
73
CY2016Q1 nhc Proceeds Payments Tax Benefit Expense From Stockbased Compensation
ProceedsPaymentsTaxBenefitExpenseFromStockbasedCompensation
-1186000
CY2015Q1 nhc Proceeds Payments Tax Benefit Expense From Stockbased Compensation
ProceedsPaymentsTaxBenefitExpenseFromStockbasedCompensation
218000
CY2016Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
17598000
CY2015Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
16654000
CY2016Q1 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
3440000
CY2015Q4 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
3440000
CY2016Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
17891000
CY2015Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
20128000
CY2016Q1 dei Document Period End Date
DocumentPeriodEndDate
2016-03-31
CY2016Q1 dei Document Type
DocumentType
10-Q
CY2016Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81732000
CY2016Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
294044000
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
286034000
CY2016Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
98147000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
86921000
CY2016Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1238000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2237000
CY2016Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
197135000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
84095000
CY2016Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
50714000
CY2015Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
65338000
CY2016Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
348562000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
339241000
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
60922000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
53364000
CY2016Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
217896000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
209469000
CY2015Q1 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
218000
CY2016Q1 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-1186000
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
286000
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
478000
CY2016Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6520000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5583000
CY2016Q1 us-gaap Assets
Assets
1068048000
CY2015Q4 us-gaap Assets
Assets
1045329000
CY2016Q1 us-gaap Assets Current
AssetsCurrent
296266000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
278942000
CY2016Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
357682000
CY2015Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
335348000
CY2016Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
166959000
CY2015Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
171174000
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
201350000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
65345000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
71442000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
66031000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
70223000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
78927000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
74747000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
79575000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
74671000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
995000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
1694000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
951000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
1699000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
21692000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
23291000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
21616000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
23273000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
168173000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
169866000
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15264139
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15000616
CY2015Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
5996000
CY2016Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
CY2016Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
6106000
CY2016Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3328000
CY2015Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3279000
CY2016Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
29378000
CY2015Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
30228000
CY2016Q1 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
41167000
CY2016Q1 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
5200000
CY2016Q1 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
5200000
CY2016Q1 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
5200000
CY2016Q1 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
5200000
CY2016Q1 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
5200000
CY2016Q1 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
15167000
CY2016Q1 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
8461000
CY2016Q1 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
32706000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38208000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69767000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49183000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78211000
CY2016Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
49183000
CY2015Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
38208000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10975000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8444000
CY2016Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2015Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.34
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15264139
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15000616
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
153000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
150000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21257000
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15522000
CY2016Q1 us-gaap Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount
ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount
3440000
CY2015Q4 us-gaap Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount
ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount
3440000
CY2016Q1 us-gaap Costs And Expenses
CostsAndExpenses
211964000
CY2015Q1 us-gaap Costs And Expenses
CostsAndExpenses
204971000
CY2016Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
5473000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3315000
CY2016Q1 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
15240000
CY2015Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
9096000
CY2016Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8316000
CY2015Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8451000
CY2016Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9354000
CY2015Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8933000
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9354000
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8933000
CY2015Q1 us-gaap Dividends Common Stock
DividendsCommonStock
4834000
CY2016Q1 us-gaap Dividends Common Stock
DividendsCommonStock
6105000
CY2016Q1 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-3170000
CY2016Q1 us-gaap Goodwill
Goodwill
17600000
CY2015Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2168000
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2016Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.388
CY2015Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.389
CY2016Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2851000
CY2015Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2951000
CY2016Q1 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
279000
CY2015Q1 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
341000
CY2015Q4 us-gaap Goodwill
Goodwill
17600000
CY2016Q1 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
11482000
CY2015Q1 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
10346000
CY2016Q1 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
218106000
CY2015Q1 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
212061000
CY2016Q1 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
229588000
CY2015Q1 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
222407000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
22397000
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
21658000
CY2016Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1505000
CY2015Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1119000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8698000
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8416000
CY2016Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
CY2015Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3203000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-2237000
CY2015Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
4839000
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-478000
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4708000
CY2016Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-14624000
CY2015Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-14186000
CY2016Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
206000
CY2015Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-60000
CY2016Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-1477000
CY2015Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
2294000
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2158000
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2033000
CY2016Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
129000
CY2015Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
442000
CY2016Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-3203000
CY2015Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-4727000
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-270000
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-14000
CY2016Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
6749000
CY2015Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
8707000
CY2016Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
494000
CY2015Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
804000
CY2016Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
953000
CY2015Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
854000
CY2015Q1 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
8018000
CY2016Q1 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
6519000
CY2015Q1 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
2328000
CY2016Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
194275
CY2015Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
369950
CY2016Q1 us-gaap Interest Expense
InterestExpense
954000
CY2015Q1 us-gaap Interest Expense
InterestExpense
590000
CY2016Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1407000
CY2015Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1227000
CY2016Q1 us-gaap Inventory Net
InventoryNet
7298000
CY2015Q4 us-gaap Inventory Net
InventoryNet
7568000
CY2016Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
37246000
CY2015Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
37683000
CY2016Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
130020000
CY2015Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
125716000
CY2016Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
10327000
CY2015Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
9985000
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1068048000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1045329000
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
138808000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
150656000
CY2016Q1 us-gaap Long Term Debt
LongTermDebt
120000000
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
120000000
CY2016Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
110000000
CY2016Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
10000000
CY2016Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
120000000
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
120000000
CY2016Q1 us-gaap Malpractice Loss Contingency Number Of Claims
MalpracticeLossContingencyNumberOfClaims
38
CY2016Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
125871000
CY2015Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
116168000
CY2016Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
61309000
CY2015Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
59747000
CY2016Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15769000
CY2016Q1 us-gaap Marketable Securities Restricted Current
MarketableSecuritiesRestrictedCurrent
15260000
CY2015Q4 us-gaap Marketable Securities Restricted Current
MarketableSecuritiesRestrictedCurrent
18276000
CY2016Q1 us-gaap Marketable Securities Restricted Noncurrent
MarketableSecuritiesRestrictedNoncurrent
152913000
CY2015Q4 us-gaap Marketable Securities Restricted Noncurrent
MarketableSecuritiesRestrictedNoncurrent
151590000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1683000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2079000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8439000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13858000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17731000
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24381000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
13699000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
13242000
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13699000
CY2015Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11074000
CY2016Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
1656000
CY2015Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
460000
CY2016Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
13270000
CY2015Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
12704000
CY2016Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
10
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
17624000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
17436000
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
373400000
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
34200000
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
34200000
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
34200000
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
34200000
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
34200000
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
202400000
CY2016Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
10071000
CY2015Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
9865000
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
231658000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
230341000
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2280000
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7558000
CY2016Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
279000
CY2015Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
341000
CY2016Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
4667000
CY2015Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
1366000
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
12504000
CY2015Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
3987000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16294000
CY2016Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4773000
CY2015Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4222000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12192000
CY2016Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16788000
CY2016Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
11482000
CY2015Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
10346000
CY2016Q1 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2015 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2016Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5995000
CY2015Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4792000
CY2016Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
CY2015Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
2168000
CY2016Q1 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
904000
CY2015Q1 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
323000
CY2016Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
1844000
CY2015Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
42000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13432000
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12580000
CY2016Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
11079000
CY2015Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
8417000
CY2016Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
CY2015Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2168000
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3124000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2171000
CY2016Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
77000
CY2015Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
114000
CY2016Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9330000
CY2015Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5036000
CY2016Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
15573000
CY2015Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
15408000
CY2016Q1 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
15573000
CY2015Q1 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
15408000
CY2016Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
888686000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
875287000
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
540124000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
536046000
CY2016Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1885000
CY2015Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1981000
CY2016Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
279000
CY2015Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
341000
CY2016Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
801000
CY2015Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
755000
CY2016Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
14455000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
11106000
CY2016Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
12142000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
8793000
CY2016Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2313000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2313000
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
375607000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
368013000
CY2016Q1 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">D</div><div style="display: inline; font-style: italic;">eferred Revenue </div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"></div></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Deferred revenue includes the deferred gain on the sale of assets to National Health Corporation (&#x201c;National&#x201d;), the non-refundable portion</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> (10%) of CCRC entrance fees being amortized over the remaining life expectancies of the residents, and premiums received within our workers&#x2019; compensation and professional liability companies that are not yet earned. </div></div></div></div>
CY2015Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
98508000
CY2016Q1 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
27402000
CY2016Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
101674000
CY2015Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
27069000
CY2016Q1 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
74272000
CY2015Q4 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
71439000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
286000
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
478000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0274
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0273
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.149
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.165
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0061
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0071
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
155459
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
52.34
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
656
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
46.69
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
56210
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
12239
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1557000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
954678
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
621390
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
167698
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.92
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
48.15
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
53.01
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
47.06
CY2016Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
47.06
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
61.47
CY2016Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
61.59
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y73D
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1548000
CY2016Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
53.01
CY2016Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P2Y219D
CY2016Q1 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
1204000
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
389498
CY2016Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
465275
CY2015Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5036000
CY2016Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9330000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
734148000
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
748400000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
630996000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
654578000
CY2016Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13434000
CY2016Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
3354000
CY2016Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
175000
CY2015Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
209000
CY2016Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
5831000
CY2016Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Estimates and Assumptions</div></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and could cause our reported net income to vary significantly from period to period.</div></div></div></div>
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15135446
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14289800
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14916905
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13761561

Files In Submission

Name View Source Status
0001047335-16-000214-index-headers.html Edgar Link pending
0001047335-16-000214-index.html Edgar Link pending
0001047335-16-000214.txt Edgar Link pending
0001047335-16-000214-xbrl.zip Edgar Link pending
exhibit311adams.htm Edgar Link pending
exhibit312daniel.htm Edgar Link pending
exhibit32nhc.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nhc-20160331.xml Edgar Link completed
nhc-20160331.xsd Edgar Link pending
nhc-20160331_cal.xml Edgar Link unprocessable
nhc-20160331_def.xml Edgar Link unprocessable
nhc-20160331_lab.xml Edgar Link unprocessable
nhc-20160331_pre.xml Edgar Link unprocessable
nhcmarch2016form10q.htm Edgar Link pending
nhcmarch2016form10q002.gif Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending